Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Debt to Equity: 2011-2019

Historic Debt to Equity for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Mar 2019 value amounting to $1.61.

  • EyePoint Pharmaceuticals' Debt to Equity rose 2.55% to $1.61 in Q1 2019 from the same period last year, while for Mar 2019 it was $1.61, marking a year-over-year increase of 2.55%. This contributed to the annual value of $1.48 for FY2018, which is N/A change from last year.
  • As of Q1 2019, EyePoint Pharmaceuticals' Debt to Equity stood at $1.61, which was up 243.31% from $0.47 recorded in Q4 2018.
  • EyePoint Pharmaceuticals' Debt to Equity's 5-year high stood at $1.61 during Q1 2019, with a 5-year trough of $0.37 in Q3 2018.
  • In the last 2 years, EyePoint Pharmaceuticals' Debt to Equity had a median value of $1.48 in 2018 and averaged $1.10.
  • Data for EyePoint Pharmaceuticals' Debt to Equity shows a peak YoY increased of 2.55% (in 2019) over the last 5 years.
  • EyePoint Pharmaceuticals' Debt to Equity (Quarterly) stood at $0.47 in 2018, then rose by 2.55% to $1.61 in 2019.
  • Its last three reported values are $1.61 in Q1 2019, $0.47 for Q4 2018, and $0.37 during Q3 2018.